Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy
暂无分享,去创建一个
A. Isacchi | C. Mercurio | F. Colotta | M. Ciomei | D. Ballinari | F. Fiorentini | W. Pastori | M. Brasca | A. Galvani | F. Roletto | E. Pesenti | R. Alzani | J. Moll | N. Avanzi | C. Festuccia | V. Patton | G. Locatelli | C. Albanese | N. Amboldi